Cancer Education and Research Institute (CERI)'s Cancer Education Programs
Our Team of cancer experts at Cancer Education and Research Institute® (CERI)'s, formerly Cancer Research Simplified, provides you with the most reliable, most up-to-date, and simplified cancer information available. Our educational programs quickly became trusted and highly sought after worldwide.
CERI strongly stands behind the importance of cancer patient empowerment and is a worldwide leading source for simplified, multi-language cancer education. Knowledge is power and empowerment is the key for greater treatment success, early diagnosis, as well as cancer prevention.
For any questions or requests, please submit your inquiry at our CERI Personalized Patient Program™ page.
CERI strongly stands behind the importance of cancer patient empowerment and is a worldwide leading source for simplified, multi-language cancer education. Knowledge is power and empowerment is the key for greater treatment success, early diagnosis, as well as cancer prevention.
For any questions or requests, please submit your inquiry at our CERI Personalized Patient Program™ page.
Myeloma | Multiple Myeloma
Aygün Sahin, MSc, PhD | CEO and Cancer Lead, Cancer Education and Research Institute (CERI)
What is Myeloma and what are the forms of Myeloma?
What are the facts and statistics for Multiple Myeloma?
What are the Symptoms of Multiple Myeloma
What are the diagnostic methods and tests for Multiple Myeloma?
Resources:
- Werner, R. A Massage Therapist's Guide to Pathology, Fourth Edition, Wolters Kluwer, 2009.
- medlineplus.gov/multiplemyeloma - accessed on 3/22/2020
- Johns Hopkins Family Health Book, First Edition, 1999.
- mayoclinic.org/diseases-conditions/multiple-myeloma/diagnosis-treatment/drc-20353383 - accessed on 3/28/2020
- Qurrat Ul Ain Iqbal and Haroon Javaid Majid. Plasmacytoma. August 7, 2021. https://www.ncbi.nlm.nih.gov/books/NBK573076/ - accessed on 3/9/2022
FDA approved treatments for Myeloma, Multiple Myeloma
You might also like:
|
|
|
|
Disclaimer: We can not assume responsibility of misinterpretation of content.